Clinical Trial Update: Quality of Life Study With Adalimumab in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 trial evaluating the quality of life effects of adalimumab in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED